*JUNE 2022: WE WILL ATTEND AND PRESENT AT THE EUROPEAN HEMATOLOGY ASSOCIATION CONGRESS. LOOKING FORWARD TO EXCITING SCIENCE AND MEETINGS. *APRIL 2022: We presented work related to mechanisms conferring resistance to glucocorticoids IN LEUKEMIA at the UNIVERSITY OF ILLINOIS, Department of Pharmacology & Regenerative Medicine. VERY ENJOYABLE VIRTUAL VISIT AND GREAT FEEDBACK. THANK YOU TO KOSTA PAJCINI AND Jae-Won Shin FOR THE KIND INVITATION. *APRIL-JUNE 2022: IGOR, BIJAL AND CRISTINA JOINED OUR GROUP. WELCOME AND WE LOOK FORWARD TO EXCITING TIMES AHEAD! *January 2022: Jonas, jolien and wouter officially joined our group. WELCOME GUYS! *December 2021: Blanca successfully defended her PHD THESIS ON "Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Acute Leukemia" *November 2021: We presented our work over a virtual cell symposium on overcoming therapy resistance in cancer *October 2021: We presented our work over a virtual visit at the institute of molecular medicine, AT THE UNIVERSITY OF LISBON. *September 2021: we welcome applications from lab technicians, students and postdocs with wet lab and bioinformatics expertise. *JUNE 2021: CELESTE DEFENDED HER graduate WORK on "CTCF BINDING PATTERNS IN T CELL ACUTE LYMPHOBLASTIC LEUKAEMIA" *APRIL 2021. CUIJUAN AND PANOS PRESENTED WORK AT THE Keystone Hematopoiesis (virtual conference) *MARCH 2021: we receive FUNDING FROM FLANDERS in belgium TO SET UP THE GROUP IN GHENT UNIVERSITY (BRUSSELS TIMES & fwo-odysseus) *AUGUST 2020: YALU PRESENTED HER WORK AT THE CSHL VIRTUAL MEETING ON MECHANISMS AND MODELS OF CANCER *JULY 2020: Yalu presented her work at the blood and bone virtual seminar series *SUMMER OF 2020: TWO PUBLICATIONS FROM OUR LABORATORY ARE OUT IN CANCER DISCOVERY AND GENOME BIOLOGY *FEBRUARY 2020:WE PRESENTED OUR WORK AT THE Blood Research Institute Lecture Series, Milwaukee *FEBRUARY 2020: WE PRESENTED OUR WORK AT THE Forth Annual Bermuda Principles Conference,“Impact on Transcriptomics”, Bermuda *June 2019: Panos presentED in the 3rd International Aegean Conference on Cytokine Signaling in Cancer *May 2019: Panos presentED in the Epigenomics Seminar Series, Mayo Clinic *April 2019: Celeste and Blanca presented posters on their projects in Feinberg Research Day *December 2018: Panos presented at the Simpson Querrey Center for Epigenetics at Northwestern University, Annual Symposium *November 2018: Panos presented at “Current and Future Directions in Leukemia Research", Celebrating 15 years of the Aifantis Lab *September 2018: Our paper on the role of deubiquitination in T cell leukemia is out in Clinical Cancer Research *May 2018: ECOG-ACRIN Spring 2018 Group Meeting, Chicago *May 2018: Panos presented in the ECOG-ACRIN Group Meeting in Chicago *February 2018: Panos presented at the The Chicago Blood Stem Cell Club *February 2018: Panos presented at the Keystone Symposia on “Cancer Epigenetics: New Mechanisms, New Therapies” *February 2018: Panos presented at the Keystone Symposia on “Ubiquitin Signaling” *June 2017: The Lab welcomes two new members/students Celeste (MSTP) and Blanca (DGP)! Blanca is a Fullbright Scholar * June 2017: Panos presented our work over the European Hematology Association Annual Meeting *May 2017: Panos presented our work over the second International Conference on “Cytokine Signaling in Cancer” *March 2017: Kelly and Panos were awarded the Best Poster Award in the “T-ALL Workshop” (Belgium) *February 2017: Panos presented in the Keystone Symposium on “Epigenetics and Human Disease: Progress from Mechanisms to Therapeutics” *January 2017: The Lab welcomes two new postdoctoral Fellows, Qi and Mina *November 2016: Congrats to Kelly on receiving the American Society of Hematology Scholar award! *September 2016: Panos publishes a review on epigenetic deregulation in hematopoietic malignancies in Nature Immunology *August 2016: We hosted Sara and her family. We really enjoyed this exciting visit! *April 2016: Our group publishes a beautiful review in Current Opinions in Genetics and Development. Congrats to Kelly and Carlos! *May 2016: Kelly is funded by the Cancer Smashers. Well done Kelly! *September 2015: The lab starts its operations